Skip to main content

What the FDA labels say about taking them together

Cobicistat and risperidone

Cobicistat's FDA label of February 10, 2026 names risperidone in its drug interactions section; the risperidone labels PlainMeds reads (4) do not name cobicistat. The cobicistat label: “A decrease in the dose of antipsychotics that are metabolized by CYP3A or CYP2D6 may be needed upon coadministration.”

Check it at the source: the cobicistat FDA label on DailyMed (effective February 10, 2026, Gilead Sciences, Inc.); the risperidone FDA label on DailyMed (effective May 28, 2026, Janssen Pharmaceuticals, Inc.).

What does the cobicistat label say about risperidone?

Cobicistat label, drug interactions

Concomitant Drug Class/Drug Name: Other antipsychotics: e.g., perphenazine risperidone thioridazine; Potential Effect ↑ = Increase, ↓ = Decrease, ↔ = No change: ↑ antipsychotic; Clinical Comment: A decrease in the dose of antipsychotics that are metabolized by CYP3A or CYP2D6 may be needed upon coadministration.

Source: FDA drug label (Tybost), Gilead Sciences, Inc., effective February 10, 2026 (SPL set 3784c35c-e87f-410c-900b-8fd6313c6010), via openFDA; the full label on DailyMed

What does the risperidone label say about cobicistat?

Risperidone's label (effective May 28, 2026) and its 3 other brand-application labels do not name cobicistat in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (RISPERDAL), Janssen Pharmaceuticals, Inc., effective May 28, 2026 (SPL set 7e117c7e-02fc-4343-92a1-230061dfc5e0), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Cobicistat generic labelers
37Risperidone generic labelers
CobicistatRisperidone
Labeled forHIVBipolar disorder, Schizophrenia
Boxed warningNoYes
Pharmacy cost (NADAC)n/a$0.0368 per tablet 0.25 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?